Option Care Health, Inc. reported a significant increase in its financial performance for the fiscal year ending December 31, 2025, with net revenue reaching $5.65 billion, a 13% increase from $5.00 billion in 2024. The company's gross profit also rose to $1.09 billion, up 7.4% from the previous year, although the gross profit margin decreased slightly to 19.3% from 20.3%. The increase in revenue was primarily driven by organic growth in both acute and chronic therapy portfolios, with acute revenue experiencing mid-teens growth and chronic revenue growing in the low double-digits. However, the cost of revenue increased by 14.5%, reflecting the higher therapy mix and associated costs.
In terms of operational developments, Option Care Health expanded its national footprint to 196 locations across 43 states, supported by a workforce of over 6,500 full-time and 1,700 part-time employees. The company also completed the acquisition of Intramed Plus, Inc. for $117.2 million, which contributed to an increase in goodwill to $1.61 billion. The acquisition is expected to enhance the company's service offerings and operational efficiencies. Additionally, the company has been actively repurchasing shares, with a total of $310 million spent on stock buybacks during 2025, reflecting its commitment to returning value to shareholders.
The company’s strategic focus on enhancing its service offerings and expanding its market presence is evident in its partnerships with managed care organizations and health systems. For the year ended December 31, 2025, approximately 88% of the company's revenue was derived from third-party payers, including managed care organizations and government programs like Medicare and Medicaid. The company reported that its largest payer accounted for about 14% of total revenue, with no other single payer exceeding 10%. This diversification in revenue sources is crucial for mitigating risks associated with changes in payer relationships.
Looking ahead, Option Care Health anticipates continued challenges in maintaining its gross profit margins due to shifts in therapy mix and increased competition in the home infusion market. Management expects these dynamics to negatively impact gross profit by an estimated $25 million to $35 million in 2026. The company remains focused on leveraging its existing infrastructure to control costs while pursuing strategic acquisitions and investments to support future growth. The outlook reflects a cautious optimism as the company navigates a competitive landscape while aiming to enhance patient care and operational efficiency.
About Option Care Health, Inc.
Option Care Health, Inc. is a leading provider of home and alternate site infusion services, offering clinical management, nursing support, and care coordination for patients with complex and chronic conditions. Operating through a network of pharmacies and infusion suites across the U.S., it serves healthcare providers, payers, and pharmaceutical manufacturers by delivering cost-effective, patient-centered therapies in non-hospital settings.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.